Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CFSAN Constituent Updates

CFSAN Constituent Updates Home
          Food
          News & Events from CFSAN
          CFSAN Constituent Updates
          FDA Extends the Public Comment Period for the Comprehensive, Multi-Year Nutrition Innovation StrategyCFSAN Constituent Updates FDA Extends the Public Comment Period for the Comprehensive, Multi-Year Nutrition Innovation Strategy
  
  	
    Share
    Post
    Linkedin

    Email
    PrintConstituent Update

August 16, 2018

The U.S. Food and Drug Administration is extending the public comment period for the agency’s Nutrition Innovation Strategy by 45 days. The docket will now remain open until *October 11, 2018*. The comment period for the notice of public meeting and request for comments published in the Federal Register on June 27, 2018.

FDA is extending the comment period in response to numerous stakeholder requests for additional time and an opportunity to review the public meeting materials. FDA will post materials from the July 26, 2018 Nutrition Innovation Strategy public meeting to provide more information to those wishing to comment on the open docket. The additional materials will include speaker presentation slides, breakout session summary notes, and the meeting transcript.

To submit comments to the docket electronically, visit http://www.regulations.gov and type FDA-2018-N-2381in the search box.

To submit comments to the docket by mail, use the following address.

Dockets Management Staff (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
Please be sure to include docket number FDA-2018-N-2381 on each page of your written comments.

**For Additional Information**

Public Meeting Page

                                                                                  Content current as of:
      09/12/2018
              
              
Regulated Product(s)
		 Food & BeveragesCFSAN Constituent Updates
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop